Role of A2B Adenosine Receptor Signaling in Adenosine-dependent Pulmonary Inflammation and Injury

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2006 Jul 15

PMID 16841096

Citations 124

Authors

Chun-Xiao Sun

Hongyan Zhong

Amir Mohsenin

Eva Morschl

Janci L Chunn

Jose G Molina

Luiz Belardinelli

Dewan Zeng

Michael R Blackburn

Affiliations

Soon will be listed here.

Abstract

Adenosine has been implicated in the pathogenesis of chronic lung diseases such as asthma and chronic obstructive pulmonary disease. In vitro studies suggest that activation of the A2B adenosine receptor (A2BAR) results in proinflammatory and profibrotic effects relevant to the progression of lung diseases; however, in vivo data supporting these observations are lacking. Adenosine deaminase-deficient (ADA-deficient) mice develop pulmonary inflammation and injury that are dependent on increased lung adenosine levels. To investigate the role of the A2BAR in vivo, ADA-deficient mice were treated with the selective A2BAR antagonist CVT-6883, and pulmonary inflammation, fibrosis, and airspace integrity were assessed. Untreated and vehicle-treated ADA-deficient mice developed pulmonary inflammation, fibrosis, and enlargement of alveolar airspaces; conversely, CVT-6883-treated ADA-deficient mice showed less pulmonary inflammation, fibrosis, and alveolar airspace enlargement. A2BAR antagonism significantly reduced elevations in proinflammatory cytokines and chemokines as well as mediators of fibrosis and airway destruction. In addition, treatment with CVT-6883 attenuated pulmonary inflammation and fibrosis in wild-type mice subjected to bleomycin-induced lung injury. These findings suggest that A2BAR signaling influences pathways critical for pulmonary inflammation and injury in vivo. Thus in chronic lung diseases associated with increased adenosine, antagonism of A2BAR-mediated responses may prove to be a beneficial therapy.

Citing Articles

A adenosine receptor signaling and regulation.

Gao Z, Haddad M, Jacobson K Purinergic Signal. 2024; .

PMID: 38833181 DOI: 10.1007/s11302-024-10025-y.

ADA2 regulates inflammation and hematopoietic stem cell emergence via the AR pathway in zebrafish.

Brix A, Belleri L, Pezzotta A, Pettinato E, Mazzola M, Zoccolillo M Commun Biol. 2024; 7(1):615.

PMID: 38777862 PMC: 11111730. DOI: 10.1038/s42003-024-06286-3.

CD73/adenosine axis exerts cardioprotection against hypobaric hypoxia-induced metabolic shift and myocarditis in a sex-dependent manner.

Ndzie Noah M, Mprah R, Wowui P, Adekunle A, Adu-Amankwaah J, Tan R Cell Commun Signal. 2024; 22(1):166.

PMID: 38454449 PMC: 10918954. DOI: 10.1186/s12964-024-01535-8.

Therapeutic Targets and Precision Medicine in COPD: Inflammation, Ion Channels, Both, or Neither?.

Bolger G Int J Mol Sci. 2023; 24(24).

PMID: 38139192 PMC: 10744217. DOI: 10.3390/ijms242417363.

Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance.

Gjuka D, Adib E, Garrison K, Chen J, Zhang Y, Li W Cancer Cell. 2023; 41(10):1774-1787.e9.

PMID: 37774699 PMC: 10591910. DOI: 10.1016/j.ccell.2023.09.005.

References

Day Y, Marshall M, Huang L, McDuffie M, Okusa M, Linden J . Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol. 2004; 286(2):G285-93. DOI: 10.1152/ajpgi.00348.2003. View

Chunn J, Molina J, Mi T, Xia Y, Kellems R, Blackburn M . Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol. 2005; 175(3):1937-46. DOI: 10.4049/jimmunol.175.3.1937. View

Shapiro S . The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160(5 Pt 2):S29-32. DOI: 10.1164/ajrccm.160.supplement_1.9. View

Varani K, Merighi S, Gessi S, Klotz K, Leung E, Baraldi P . [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol. 2000; 57(5):968-75. View

Blackburn M, Volmer J, Thrasher J, Zhong H, Crosby J, Lee J . Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med. 2000; 192(2):159-70. PMC: 2193256. DOI: 10.1084/jem.192.2.159. View

Martin C, Leone M, Viviand X, Ayem M, Guieu R . High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med. 2000; 28(9):3198-202. DOI: 10.1097/00003246-200009000-00014. View

Blackburn M, Aldrich M, Volmer J, Chen W, Zhong H, Kelly S . The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J Biol Chem. 2000; 275(41):32114-21. DOI: 10.1074/jbc.M005153200. View

Underwood D, OSBORN R, Bochnowicz S, WEBB E, Rieman D, Lee J . SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol. 2000; 279(5):L895-902. DOI: 10.1152/ajplung.2000.279.5.L895. View

Sperlagh B, DODA M, Baranyi M, Hasko G . Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J Neuroimmunol. 2000; 111(1-2):45-54. DOI: 10.1016/s0165-5728(00)00365-9. View

10.

Beukers M, den Dulk H, van Tilburg E, Brouwer J, IJzerman A . Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine. Mol Pharmacol. 2000; 58(6):1349-56. DOI: 10.1124/mol.58.6.1349. View

11.

Dubey R, Gillespie D, Zacharia L, Mi Z, Jackson E . A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension. 2001; 37(2 Pt 2):716-21. DOI: 10.1161/01.hyp.37.2.716. View

12.

Linden J . Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001; 41:775-87. DOI: 10.1146/annurev.pharmtox.41.1.775. View

13.

King Jr T, Schwarz M, Brown K, Tooze J, Colby T, Waldron Jr J . Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001; 164(6):1025-32. DOI: 10.1164/ajrccm.164.6.2001056. View

14.

Chunn J, Young H, BANERJEE S, Colasurdo G, Blackburn M . Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol. 2001; 167(8):4676-85. DOI: 10.4049/jimmunol.167.8.4676. View

15.

Fredholm B, IJzerman A, Jacobson K, Klotz K, Linden J . International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001; 53(4):527-52. PMC: 9389454. View

16.

Ohta A, Sitkovsky M . Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2002; 414(6866):916-20. DOI: 10.1038/414916a. View

17.

Matsuoka H, Arai T, Mori M, Goya S, Kida H, Morishita H . A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2002; 283(1):L103-12. DOI: 10.1152/ajplung.00187.2001. View

18.

Lanone S, Zheng T, Zhu Z, Liu W, Lee C, Ma B . Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest. 2002; 110(4):463-74. PMC: 150413. DOI: 10.1172/JCI14136. View

19.

Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G . Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002; 20(6):1393-8. DOI: 10.1183/09031936.02.00005002. View

20.

Blackburn M . Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci. 2003; 24(2):66-70. DOI: 10.1016/S0165-6147(02)00045-7. View